Caresyntax raised £140M ($180M) in a Series C extension led by surgical.ai to enhance AI-enabled surgical software and support strategic acquisitions.
Caresyntax raised £140M ($180M) in a Series C extension led by surgical.ai to enhance AI-enabled surgical software and support strategic acquisitions.
08/15/24, 2:41 PM
Location
san franciscoMoney raised
£140 million
Industry
software
Round Type
series c
Investors
Surgical.Ai
Surgical.ai has participated in a £140 million ($180 million) Series C extension for Caresyntax. This funding aims to expedite the adoption and development of AI-enabled surgical software while supporting strategic mergers and acquisitions.
Company Info
Location
san francisco, california, united states
Additional Info
At Caresyntax, we are dedicated to making surgery safer and smarter. Our mission is to converge AI-powered software, devices, and clinical services to help our customers improve surgical outcomes. Our platform, an enterprise-grade surgical intelligence system, is vendor-neutral and equipped with proprietary software, hardware, and advanced AI capabilities. It can ingest and analyze data throughout the surgical workflow, including EMR, video, audio, image, device data, financial and outcomes data, and clinical and operational metrics to capture a complete picture of the surgical pathway.